Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05507931 · ClinicalTrials.gov registry record · NA

Broccoli Sprouts for Mild Ulcerative Colitis

A NA study of Ulcerative Colitis and Ulcerative Colitis Chronic Mild, sponsored by University of Michigan.

Completed
Registry status
NA
Development phase
23
Enrollment target
1
Study location

NCT05507931 is a NA study of Ulcerative Colitis and Ulcerative Colitis Chronic Mild that has completed, run by University of Michigan. The registered enrollment target is 23 participants, below the 2,057-participant average among 122 other Ulcerative Colitis trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05507931, a NA study of Ulcerative Colitis and Ulcerative Colitis Chronic Mild, has completed, sponsored by University of Michigan.

COMPLETED
Registry status
NA
Development phase
23 participants
Enrollment target
1
Study location

Study Summary

The goal of this study is to determine the number of servings of broccoli sprouts sufficient to (1) increase sulforaphane levels in the stool and blood and (2) reduce inflammatory markers in patients with mild ulcerative colitis. This is a pilot feasibility study to prepare for a larger randomized controlled trial.

Interventions

  • DIETARY_SUPPLEMENT 1 Serving of broccoli sprouts
  • DIETARY_SUPPLEMENT 3 Servings of broccoli sprouts

Study Locations (1)

Michigan

  • University of Michigan - Ann Arbor

Trial Details

FieldValue
Enrollment Target 23 participants
Start Date 2023-05-23
Est. Completion 2026-01-09
Phase NA

Sponsor

University of Michigan

1,327 total trials

What the Registry Record Tells You About NCT05507931

The ClinicalTrials.gov registry entry for NCT05507931 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,057-participant average among 122 other Ulcerative Colitis trials with a reported enrollment target (99% lower). The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Ulcerative Colitis appearing as the primary indexed condition, and to 2 interventions - of which 1 Serving of broccoli sprouts is the first listed.

NCT05507931 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.

Frequently Asked Questions

What is clinical trial NCT05507931 about?

NCT05507931 is a clinical study titled "Broccoli Sprouts for Mild Ulcerative Colitis". The goal of this study is to determine the number of servings of broccoli sprouts sufficient to (1) increase sulforaphane levels in the stool and blood and (2) reduce inflammatory markers in patients with mild ulcerative colitis. This is a pilot feasibility study to prepare for a larger randomized c...

What is the current status of trial NCT05507931?

This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2023-05-23. Estimated completion is 2026-01-09.

What conditions does trial NCT05507931 study?

This clinical trial studies the following conditions: Ulcerative Colitis, Ulcerative Colitis Chronic Mild.

What interventions are being tested in trial NCT05507931?

The interventions under investigation include: 1 Serving of broccoli sprouts (DIETARY_SUPPLEMENT), 3 Servings of broccoli sprouts (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT05507931?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05507931 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Ulcerative Colitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.